Financials
- Market Capitalization 5.32 B
- Employee 8 500
- Founded 2002
- CEO Chintu PatelChirag Patel
- Website www.amneal.com
- Headquarter N/A
- FIGI BBG00462PGG0
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 998 | ALKS Alkermes plc - Ordinary Shares | 51.60 USD | -0.52% | -5.09% | +15.75% | +78.86% | 8.60 B USD | ||
| 1142 | LNTH Lantheus Holdings, Inc. - Common Stock | 102.37 USD | -2.87% | -0.82% | -2.50% | +82.61% | 6.66 B USD | ||
| 1358 | INDV Indivior Pharmaceuticals, Inc. - Common Stock | 40.23 USD | +0.05% | -1.40% | +4.17% | +19.73% | 4.90 B USD | ||
| 1772 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.65 USD | +11.88% | -2.92% | -66.71% | -61.03% | 2.79 B USD |
Frequently asked questions about Amneal Pharmaceuticals, Inc. - Class A Common Stock
What is the Amneal Pharmaceuticals, Inc. - Class A Common Stock stock price today?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock (AMRX) is 16.69. Over the past 24 hours, the stock has changed by -2.85%. Follow the AMRX chart for real-time price dynamics.
What is the stock ticker of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades under the ticker AMRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Amneal Pharmaceuticals, Inc. - Class A Common Stock stock going up?
AMRX has changed by -1.65% over the last week, +2.39% over the last month, and +58.20% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Amneal Pharmaceuticals, Inc. - Class A Common Stock net income for the last quarter?
Amneal Pharmaceuticals, Inc. - Class A Common Stock reported net income of 62.26 M for the last quarter. The previous quarter showed 35.08 M, which means net income changed by +77.49%.
How many employees does Amneal Pharmaceuticals, Inc. - Class A Common Stock have?
As of the latest available data, Amneal Pharmaceuticals, Inc. - Class A Common Stock has 8 500 employees. Workforce size can provide additional context about the company's scale and operations.
What is Amneal Pharmaceuticals, Inc. - Class A Common Stock EBITDA?
Amneal Pharmaceuticals, Inc. - Class A Common Stock EBITDA is 140.26 M, and its EBITDA margin is 19.41%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Amneal Pharmaceuticals, Inc. - Class A Common Stock stock?
You can buy Amneal Pharmaceuticals, Inc. - Class A Common Stock (AMRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Amneal Pharmaceuticals, Inc. - Class A Common Stock stock?
Investing in Amneal Pharmaceuticals, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AMRX chart and related analysis on metatrader.com as part of your research.